The Latest Breaking News from ETF

The Cold Snap Lit a Fire Under Natural Gas—3 Trades to Watch

Natural gas demand is rising as winter storms and data centers tighten supply. These three energy trades could benefit from cold-weather volatility

MarketBeat · Jan 27

Why These 3 Uranium ETFs Could Be 2026’s Most Overlooked Winners

Uranium demand and limited supply could send shares of companies held by these ETFs skyward in 2026, making them an easy way to gain broad exposure.

MarketBeat · Jan 27

2 International Dividend ETFs To Watch as the 'Sell America' Trade Gains Popularity

The "sell America" trade has been increasingly making headlines. Investors may flock to these two international dividend ETFs if the noise continues.

Barchart · Jan 27

Why ETFs Are One of the Easiest Ways to Start Investing

Broad diversification, low fees and the ability to buy fractional shares make ETFs one of the easiest ways to start investing.

Kiplinger · Jan 23

Goldman Sachs Just Hiked Its Dividend 12.5%. Should You Buy GS Stock Now?

The financial services major will now pay a dividend of $4.50 per share.

Barchart · Jan 23

325 Million Reasons to Buy Netflix Stock Today

Netflix now counts nearly 325 million paid subscribers, highlighting its vast scale despite ongoing strategic uncertainty.

Barchart · Jan 22

There's Trouble in 2026 for Tech Stock ETFs. How To Play XLK Right Now.

The tech sector is teetering in 2026, leaving many investors to wonder how they should play tech ETFs like XLK this year. Here's what to know.

Barchart · Jan 22

5 ETFs That Could Outperform the S&P 500 in the Next 5 Years

While no one can predict future market movements, there are a handful of ETFs that seem poised for outperformance.

GOBankingRates · Jan 22

3 ETFs Combining Market-Beating Performance and ESG Goals

Investors looking for outstanding returns as well as an adherence to the principles of ESG might start with these three ETFs.

MarketBeat · Jan 22

How to Invest in the New Era of Agentic AI for Biotech Stocks

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

Barchart · Jan 22